A semi-automated luminescence based standard membrane feeding assay identifies novel small molecules that inhibit transmission of malaria parasites by mosquitoes

Current first-line treatments for uncomplicated falciparum malaria rapidly clear the asexual stages of the parasite, but do not fully prevent parasite transmission by mosquitoes. The standard membrane feeding assay (SMFA) is the biological gold standard assessment of transmission reducing activity (TRA), but its throughput is limited by the need to determine mosquito infection status by dissection and microscopy. Here we present a novel dissection-free luminescence based SMFA format using a transgenic Plasmodium falciparum reporter parasite without resistance to known antimalarials and therefore unrestricted in its utility in compound screening. Analyses of sixty-five compounds from the Medicines for Malaria Venture validation and malaria boxes identified 37 compounds with high levels of TRA (>80%); different assay modes allowed discrimination between gametocytocidal and downstream modes of action. Comparison of SMFA data to published assay formats for predicting parasite infectivity indicated that individual in vitro screens show substantial numbers of false negatives. These results highlight the importance of the SMFA in the screening pipeline for transmission reducing compounds and present a rapid and objective method. In addition we present sixteen diverse chemical scaffolds from the malaria box that may serve as a starting point for further discovery and development of malaria transmission blocking drugs.

[1]  C. Janse,et al.  Removal of Heterologous Sequences from Plasmodium falciparum Mutants Using FLPe-Recombinase , 2010, PloS one.

[2]  R. Sheaff,et al.  Luciferase inhibition by a novel naphthoquinone. , 2012, Journal of photochemistry and photobiology. B, Biology.

[3]  R. Sinden,et al.  A high-throughput assay for the identification of malarial transmission-blocking drugs and vaccines. , 2012, International journal for parasitology.

[4]  Teun Bousema,et al.  Epidemiology and Infectivity of Plasmodium falciparum and Plasmodium vivax Gametocytes in Relation to Malaria Control and Elimination , 2011, Clinical Microbiology Reviews.

[5]  A. Vaughan,et al.  A scalable assessment of Plasmodium falciparum transmission in the standard membrane-feeding assay, using transgenic parasites expressing green fluorescent protein-luciferase. , 2014, Journal of Infectious Diseases.

[6]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[7]  J. Meuwissen,et al.  Infectivity of cultured Plasmodium falciparum gametocytes to mosquitoes , 1989, Parasitology.

[8]  S. Hay,et al.  The decline in paediatric malaria admissions on the coast of Kenya , 2007, Malaria Journal.

[9]  P. Garner,et al.  Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission , 2014, The Cochrane database of systematic reviews.

[10]  Farah El Mazouni,et al.  A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria , 2015, Science Translational Medicine.

[11]  N. White.  Primaquine to prevent transmission of falciparum malaria. , 2013, The Lancet. Infectious diseases.

[12]  D. Fidock,et al.  Identification of MMV Malaria Box Inhibitors of Plasmodium falciparum Early-Stage Gametocytes Using a Luciferase-Based High-Throughput Assay , 2013, Antimicrobial Agents and Chemotherapy.

[13]  D. Sullivan,et al.  Gametocytocidal Screen Identifies Novel Chemical Classes with Plasmodium falciparum Transmission Blocking Activity , 2014, PloS one.

[14]  D. Fidock,et al.  Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanil. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. Meuwissen,et al.  Cultivation of fertile Plasmodium falciparum gametocytes in semi-automated systems. 1. Static cultures. , 1982, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[16]  R. Sinden,et al.  Male and Female Plasmodium falciparum Mature Gametocytes Show Different Responses to Antimalarial Drugs , 2013, Antimicrobial Agents and Chemotherapy.

[17]  K. Matuschewski,et al.  High efficiency transfection of Plasmodium berghei facilitates novel selection procedures. , 2006, Molecular and biochemical parasitology.

[18]  David W. Gray,et al.  A novel multiple-stage antimalarial agent that inhibits protein synthesis , 2015, Nature.

[19]  D. Han,et al.  KRIBB11 Inhibits HSP70 Synthesis through Inhibition of Heat Shock Factor 1 Function by Impairing the Recruitment of Positive Transcription Elongation Factor b to the hsp70 Promoter* , 2010, The Journal of Biological Chemistry.

[20]  T. Triglia,et al.  Negative selection of Plasmodium falciparum reveals targeted gene deletion by double crossover recombination. , 2002, International journal for parasitology.

[21]  Jeremy N. Burrows,et al.  P. falciparum In Vitro Killing Rates Allow to Discriminate between Different Antimalarial Mode-of-Action , 2012, PloS one.

[22]  Strategic use of antimalarial drugs that block falciparum malaria parasite transmission to mosquitoes to achieve local malaria elimination , 2014, Parasitology Research.

[23]  R. Rosenberg.  Malaria: some considerations regarding parasite productivity. , 2008, Trends in parasitology.

[24]  Koen J. Dechering,et al.  Isolation and Functional Characterization of Two Distinct Sexual-Stage-Specific Promoters of the Human Malaria Parasite Plasmodium falciparum , 1999, Molecular and Cellular Biology.

[25]  J. Burrows,et al.  Designing the next generation of medicines for malaria control and eradication , 2013, Malaria Journal.

[26]  Manuel Llinás,et al.  Comparative whole genome transcriptome analysis of three Plasmodium falciparum strains , 2006, Nucleic acids research.

[27]  N. White.  The role of anti-malarial drugs in eliminating malaria , 2008, Malaria Journal.

[28]  T. Bousema,et al.  Rationale for short course primaquine in Africa to interrupt malaria transmission , 2012, Malaria Journal.

[29]  J. Sattabongkot,et al.  Population dynamics of sporogony for Plasmodium vivax parasites from western Thailand developing within three species of colonized Anopheles mosquitoes , 2006, Malaria Journal.

[30]  I. Gluzman,et al.  A set of independent selectable markers for transfection of the human malaria parasite Plasmodium falciparum. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[31]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.

[32]  K. Williamson,et al.  A malaria gametocytocidal assay using oxidoreduction indicator, alamarBlue. , 2011, Molecular and biochemical parasitology.

[33]  Timothy N. C. Wells,et al.  Malaria medicines: a glass half full? , 2015, Nature Reviews Drug Discovery.

[34]  E. Winzeler,et al.  The Activities of Current Antimalarial Drugs on the Life Cycle Stages of Plasmodium: A Comparative Study with Human and Rodent Parasites , 2012, PLoS medicine.

[35]  R. Sinden,et al.  Measuring the blockade of malaria transmission--an analysis of the Standard Membrane Feeding Assay. , 2012, International journal for parasitology.

[36]  R. Sinden,et al.  A Male and Female Gametocyte Functional Viability Assay To Identify Biologically Relevant Malaria Transmission-Blocking Drugs , 2014, Antimicrobial Agents and Chemotherapy.

[37]  Silvia Parapini,et al.  A Plasmodium falciparum screening assay for anti-gametocyte drugs based on parasite lactate dehydrogenase detection. , 2013, The Journal of antimicrobial chemotherapy.

[38]  A. Cowman,et al.  Negative selection using yeast cytosine deaminase/uracil phosphoribosyl transferase in Plasmodium falciparum for targeted gene deletion by double crossover recombination. , 2006, Molecular and biochemical parasitology.

[39]  V. Navratil,et al.  Identifying genomic changes associated with insecticide resistance in the dengue mosquito Aedes aegypti by deep targeted sequencing , 2015, Genome research.

[40]  P. Gething,et al.  Lead Clinical and Preclinical Antimalarial Drugs Can Significantly Reduce Sporozoite Transmission to Vertebrate Populations , 2014, Antimicrobial Agents and Chemotherapy.

[41]  Teun Bousema,et al.  Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs , 2010 .

[42]  T. Bousema,et al.  The relevance and applicability of oocyst prevalence as a read-out for mosquito feeding assays , 2013, Scientific Reports.

[43]  M. Cassera,et al.  Antiapicoplast and Gametocytocidal Screening To Identify the Mechanisms of Action of Compounds within the Malaria Box , 2013, Antimicrobial Agents and Chemotherapy.

[44]  V. Avery,et al.  Identification of inhibitors of Plasmodium falciparum gametocyte development , 2013, Malaria Journal.

[45]  J. Vanderberg,et al.  Complete in vitro maturation of Plasmodium falciparum gametocytes , 1981, Nature.

[46]  T. Bousema,et al.  A combination of new screening assays for prioritization of transmission-blocking antimalarials reveals distinct dynamics of marketed and experimental drugs. , 2015, The Journal of antimicrobial chemotherapy.

[47]  C. Siethoff,et al.  First-in-man safety and pharmacokinetics of synthetic ozonide OZ439 demonstrates an improved exposure profile relative to other peroxide antimalarials , 2012, British journal of clinical pharmacology.

[48]  A. Vaughan,et al.  A transgenic Plasmodium falciparum NF54 strain that expresses GFP-luciferase throughout the parasite life cycle. , 2012, Molecular and biochemical parasitology.

[49]  Teun Bousema,et al.  Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials , 2008, Malaria Journal.

[50]  Mollie E. Brooks,et al.  Generalized linear mixed models: a practical guide for ecology and evolution. , 2009, Trends in ecology & evolution.

[51]  G. Butcher.  Antimalarial drugs and the mosquito transmission of Plasmodium. , 1997, International journal for parasitology.

[52]  Robert W. Sauerwein,et al.  Targeting Plasmodium PI(4)K to eliminate malaria , 2013, Nature.

[53]  R. Rosenberg,et al.  The number of sporozoites produced by individual malaria oocysts. , 1991, The American journal of tropical medicine and hygiene.

[54]  Jeremy N. Burrows,et al.  The Open Access Malaria Box: A Drug Discovery Catalyst for Neglected Diseases , 2013, PloS one.

[55]  D. Mancama,et al.  Nowhere to hide: interrogating different metabolic parameters of Plasmodium falciparum gametocytes in a transmission blocking drug discovery pipeline towards malaria elimination , 2015, Malaria Journal.

[56]  T. Bousema,et al.  Substantial Contribution of Submicroscopical Plasmodium falciparum Gametocyte Carriage to the Infectious Reservoir in an Area of Seasonal Transmission , 2009, PloS one.

[57]  J. McCarthy,et al.  Effect of antimalarial drugs on Plasmodium falciparum gametocytes. , 2009, The Journal of infectious diseases.

[58]  W. Milhous,et al.  Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[59]  P Garner,et al.  Artesunate combinations for treatment of malaria: meta-analysis , 2004, The Lancet.

[60]  E. Fikrig,et al.  Anopheles gambiae circumsporozoite protein-binding protein facilitates plasmodium infection of mosquito salivary glands. , 2013, The Journal of infectious diseases.

[61]  R. Sinden,et al.  Persistence of atovaquone in human sera following treatment: inhibition of Plasmodium falciparum development in vivo and in vitro. , 2003, The American journal of tropical medicine and hygiene.

[62]  Isabel Rodriguez-Barraquer,et al.  Robust, reproducible, industrialized, standard membrane feeding assay for assessing the transmission blocking activity of vaccines and drugs against Plasmodium falciparum , 2015, Malaria Journal.